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Susanna K. P. Lau1,2,3,4*, Ching-Wan Lam5, Shirly O. T. Curreem4, Kim-Chung Lee4, Wang-Ngai Chow4, Candy C. Y. Lau4,
Siddharth Sridhar4, Sally C. Y. Wong4, Paolo Martelli6, Suk-Wai Hui6, Kwok-Yung Yuen1,2,3,4 and Patrick C. Y. Woo1,2,3,4*Abstract
Background: Burkholderia pseudomallei is an emerging pathogen that causes melioidosis, a serious and potentially
fatal disease which requires prolonged antibiotics to prevent relapse. However, diagnosis of melioidosis can be
difficult, especially in culture-negative cases. While metabolomics represents an uprising tool for studying infectious
diseases, there were no reports on its applications to B. pseudomallei. To search for potential specific biomarkers,
we compared the metabolomics profiles of culture supernatants of B. pseudomallei (15 strains), B. thailandensis
(3 strains), B. cepacia complex (14 strains), P. aeruginosa (4 strains) and E. coli (3 strains), using ultra-high performance
liquid chromatography-electrospray ionization-quadruple time-of-flight mass spectrometry (UHPLC-ESI-Q-TOF-MS).
Multi- and univariate analyses were used to identify specific metabolites in B. pseudomallei.
Results: Principal component and partial-least squares discrimination analysis readily distinguished the metabolomes
between B. pseudomallei and other bacterial species. Using multi-variate and univariate analysis, eight metabolites with
significantly higher levels in B. pseudomallei were identified. Three of the eight metabolites were identified by MS/MS,
while five metabolites were unidentified against database matching, suggesting that they may be potentially novel
compounds. One metabolite, m/z 144.048, was identified as 4-methyl-5-thiazoleethanol, a degradation product of
thiamine (vitamin B1), with molecular formula C6H9NOS by database searches and confirmed by MS/MS using
commercially available authentic chemical standard. Two metabolites, m/z 512.282 and m/z 542.2921, were
identified as tetrapeptides, Ile-His-Lys-Asp with molecular formula C22H37N7O7 and Pro-Arg-Arg-Asn with molecular
formula C21H39N11O6, respectively. To investigate the high levels of 4-methyl-5-thiazoleethanol in B. pseudomallei,
we compared the thiamine degradation pathways encoded in genomes of B. pseudomallei and B. thailandensis.
While both B. pseudomallei and B. thailandensis possess thiaminase I which catalyzes degradation of thiamine to
4-methyl-5-thiazoleethanol, thiM, which encodes hydroxyethylthiazole kinase responsible for degradation of
4-methyl-5-thiazoleethanol, is present and expressed in B. thailandensis as detected by PCR/RT-PCR, but absent or not
expressed in all B. pseudomallei strains. This suggests that the high 4-methyl-5-thiazoleethanol level in B. pseudomallei is
likely due to the absence of hydroxyethylthiazole kinase and hence reduced downstream degradation.
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Conclusion: Eight novel biomarkers, including 4-methyl-5-thiazoleethanol and two tetrapeptides, were identified in the
culture supernatant of B. pseudomallei.
Keywords: Burkholderia pseudomallei, Biomarkers, Specific, MetabolomicsBackground
Burkholderia pseudomallei is an emerging, highly patho-
genic, Gram-negative betaproteobacterium that causes
melioidosis, a potentially serious and fatal disease often
manifested as severe community-acquired pneumonia and
sepsis. The bacterium is classified as a category B bioter-
rorism agent by the Center for Disease Control, USA. Al-
though melioidosis is mainly endemic in Southeast Asia
and northern Australia, the disease has been increasingly
reported in countries outside the Asia-Pacific region, such
as India [1, 2], Mauritius [3], South, Central and North
America [4–6], and West and East Africa [7, 8], suggesting
an expanding geographical distribution. B. pseudomallei is
a natural saprophyte and melioidosis is believed to be ac-
quired through environmental contact with contaminated
soil and water [9, 10]. Illness can be presented as an acute,
subacute, or chronic process, with an incubation period of
up to 26 years [11]. The disease manifestations can range
from subclinical infection, localized abscesses, pneumonia
to fulminant sepsis, leading to a mortality rate of up to
19 % [12]. Besides human, melioidosis also affects a wide
range of animals in endemic areas [10, 13]. Treatment of
melioidosis is often difficult, as B. pseudomallei is usually
resistant to multiple antibiotics and prolonged antibiotics
are required to prevent relapse [14, 15]. Moreover, diag-
nostic and therapeutic resources in endemic areas are often
limited, which have hindered efforts to improve treatment
outcomes.
Diagnosis of melioidosis can be difficult, as the bacter-
ium may not be readily isolated from clinical specimens.
And even with positive cultures, commercial bacterial
identifications often fail to differentiate between B. pseudo-
mallei and closely related species such as B. thailandensis
and members of B. cepacia complex [16]. Therefore, new
molecular techniques are often required for more ac-
curate species identification [14, 17–23]. Despite these new
technologies, the diagnostic problems associated with
culture-negative cases remain unresolved. Although dif-
ferent serological tests have been developed to help diag-
nose culture-negative melioidosis, their clinical usefulness
is limited by the low sensitivities and specificities [24, 25].
Similarly, PCR assays for direct detection from blood and
sputum samples are often associated with suboptimal sen-
sitivities and specificities [23]. The availability of alterna-
tive techniques for improved diagnosis of melioidosis is
thus eagerly awaited, and such techniques should be ableto differentiate between melioidosis and infections caused
by common Gram-negative bacteria including the closely
related Burkholderia species.
Metabolomics is an uprising research platform for sys-
tematic studies of the small-molecular metabolite pro-
files of a biological system such as cell, tissue or organism,
which may be intermediate of end products of various
metabolic pathways. Using statistical analyses, the metabo-
lomes of different biological systems can be compared,
which may help differentiate between them and identify
potential metabolite markers specific to each system. The
technique has also been recently applied to characterize
various infectious diseases and pathogens, with an aim to
improve laboratory diagnosis [26–31]. In addition, the
application of metabolomics to pathogens has opened a
new arena for studying microbial metabolomics pathways
while making use of genomic data. For example, we have
recently reported a novel biosynthetic pathway for monas-
corubin, a thousand-year-old natural food colorant, in the
pathogenic dimorphic fungus, Penicillium marneffei, iden-
tified using metabolomics approach and genomics data
[32]. Despite being an important pathogen, no studies
have reported the use of metabolomics to explore specific
biomarkers in B. pseudomallei. We hypothesize that there
are potentially novel extracellular metabolites specifically
produced by B. pseudomallei that may be detected in body
fluids of patients with melioidosis. To search for potential
biomarkers for diagnosis of melioidosis, we attempted
to characterize the metabolomes of culture superna-
tants of B. pseudomallei and related species, using ultra-
high performance liquid chromatography-electrospray
ionization-quadruple time-of-flight mass spectrometry
(UHPLC-ESI-Q-TOF-MS). Multi-and univariate statis-
tical analyses of the metabolome data were used to iden-
tify specific metabolites in B. pseudomallei.
Results
Visual inspection of total ion chromatograms
We characterized and compared the metabolomes of cul-
ture supernatants from 15 B. pseudomallei (seven clinical
and eight environmental isolates), three B. thailandensis,
14 B. cepacia complex, four P. aeruginosa and three E. coli
isolates. The total ion chromatograms from the same bac-
terial species shared considerable similarity, whereas sig-
nificant differences were observed in the chromatograms
obtained between different species, except B. pseudomallei
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tive examples of chromatograms obtained from each spe-
cies are shown in Fig. 1.
PCA and PLS-DA modeling
To compare the metabolomes between B. pseudomallei
and other bacterial species, both multi- and univariate
analyses were performed. For multi-variate analysis, prin-
cipal component analysis (PCA) showed that 40.4 % of the
total variance in the data was represented by the first two
principal components (PCs) (Fig. 2a). The 2D-PCA score
plot revealed that all bacterial strains of the same species
were closely related and can be distinguished from other
bacterial species based on the first two principal compo-
nents, with the B. pseudomallei strains clearly separatedFig. 1 Total ion chromatogram of bacterial culture supernatant. Total io
(b) B. thailandensis, (c) B. cepacia complex, (d) P. aeruginosa and (e) E.
A representative chromatogram for each sample group was shownfrom other species including B. thailandensis along PC1
which represented 25.9 % of the variance. In view of the sig-
nificant separation achieved using PCA, supervised partial-
least squares discrimination analysis (PLS-DA) (Fig. 2b)
was subsequently performed to maximize the separation
and identify additional metabolites to those identified using
PCA. In the PLS-DA score plot, the separation between dif-
ferent bacterial species is more prominent. Potential me-
tabolites were selected based on the VIP score (>1). Based
on the degree of similarity of metabolite abundance pro-
files, hierarchical clustering analysis was performed to show
the global overview of all culture supernatant metabo-
lites detected (Fig. 3). Metabolites with similar abundance
pattern were positioned closer together. The heat map and
dendrogram indicated the close clustering of B. pseudomallein chromatogram of culture supernatant of (a) B. pseudomallei,
coli with UPLC-QTOF-MS performed under ESI positive mode.
Fig. 2 PCA and PLS-DA score plot based on culture supernatant. (a) PCA score plot and (b) PLS-DA score plot generated using MetaboAnalyst
based on culture supernatant in positive mode. PLS-DA models were validated using R2 and Q2 based on leave one out cross-validation (LOOCV).
Five-component model was selected as optimized model with R2 = 0.99 and Q2 = 0.99. The significance of the model was demonstrated by
permutation test with 2000 testing iterations using separation distance and P value <0.001 was obtained. BC, B. cepacia complex; BPS,
B. pseudomallei; BT, B. thailandensis; PA, P. aeruginosa; EC, E. coli
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although B. pseudomallei strains were more closely related
to B. thailandensis strains than to other species. However,
no significant difference was observed between clinical
and environmental strains of B. pseudomallei. To further
confirm the specificity and significance of potential metab-
olites identified from PCA and PLS-DA, univariate ana-
lysis of each metabolite was performed using one-way
ANOVA and Student’s t-test. A total of eight potential
metabolites contributing most to the variation between
B. pseudomallei and other bacterial species with signifi-
cantly higher level in B. pseudomallei strains were selected
for further identification (Table 1).
Identification of potential biomarkers specific to
B. pseudomallei
The metabolites were identified by MS/MS fragmenta-
tion and their predicted molecular formulae were shown in
Table 1. All metabolites except m/z 144.048 were found only
in B. pseudomallei strains but not other bacterial species.
Three (m/z 144.048, m/z 512.282 and m/z 542.2921 m/z
144.048) of the eight metabolites were identified as known
compounds, while the other five metabolites may repre-
sent potentially novel metabolites with no match against
known compounds or databases.
The metabolite m/z 144.048 was identified as 4-methyl-
5-thiazoleethanol (metabolite no. 2 in Table 1) withmolecular formula C6H9NOS by database searches in
METLIN and Massbank, and confirmed by MS/MS using
commercially available authentic chemical standard of 4-
methyl-5-thiazoleethanol (Fig. 4a). 4-methyl-5-thiazoleethanol
is a degradation product of thiamine (vitamin B1), an es-
sential cofactor in most living organisms, being important
for purine metabolism. Although it was found in B. pseu-
domallei strains with significantly higher levels (Fig. 4b),
low levels of m/z 144.048 (at approximately 100-to 1000-
fold lower levels) were also detected in B. thailandensis, B.
cepacia complex, P. aeruginosa and E. coli (Fig. 4c).
Two metabolites, m/z 512.282 and m/z 542.2921 were
identified as tetrapeptides (metabolite no. 4 and 5 in Table 1).
m/z 512.282 with molecular formula C22H37N7O7 was iden-
tified as Ile-His-Lys-Asp, and m/z 542.2921 with molecular
formula C21H39N11O6 was identified as Pro-Arg-Arg-Asn
in METLIN. Some bacteria are known to produce short
peptides as pheromones, which are involved in quorum-
sensing [33]. Future studies are required to determine the
origin and biological significance of these tetrapeptides in
B. pseudomallei.
Phylogenetic analysis of thiaminase I and hydroxyethyl
thiazole kinase genes of B. pseudomallei and
B. thailandensis
To investigate the high levels of 4-methyl-5-thiazoleethanol
in B. pseudomallei culture supernatant, we attempted to
Fig. 3 Hierarchical clustering analysis based on culture supernatant. Hierarchical clustering analysis generated using MetaboAnalyst based on
culture supernatant in positive mode. Each bar represented a metabolite colored by its abundance intensities on normalized scale from
blue (decreased level) to red (increased level). The dendrogram on the left was constructed based on the metabolite abundance profiles.
BC, B. cepacia complex; BPS, B. pseudomallei; BT, B. thailandensis; PA, P. aeruginosa; EC, E. coli
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mallei and B. thailandensis. The thiamine degrading en-
zyme, thiaminase I, which catalyzes the degradation of
thiamine to 4-methyl-5-thiazoleethanol (Fig. 5a), can be
found in available genome sequences of B. pseudomallei
and B. thailandensis [34]. Phylogenetic analysis of all bac-
terial thiaminase I genes available from GenBank showed
that the sequences from B. pseudomallei are most closely
related to that from B. thailandensis (Fig. 5b). Moreover,
the thaiminase I genes of B. pseudomallei and B. thailan-
densis were clustered with those of two other Burkhol-
deria species with sequences available, forming a distinct
cluster among all bacterial sequences. Other known bacter-
ial thiaminase I genes have only been found in phylogenet-
ically distant bacterial species, such as those Gram-positive
bacteria like Clostridium, Paenibacillus and Bacillus. The
findings suggested that Burkholderia species is unique
among Gram-negative bacteria in having acquired this
gene which may be involved in specific functions. Since
both B. pseudomallei and B. thailandensis possessed a thi-
aminase I homologue, the higher levels of 4-methyl-5-thiazoleethanol in B. pseudomallei are unlikely to be re-
lated to thiaminase I.
On the other hand, hydroxyethylthiazole kinase, encoded
by the gene, thiM, catalyzes the degradation of 4-methyl-5-
thiazoleethanol. Unlike thiaminase I gene, thiM is widely
distributed in various Gram-negative bacteria. The gene
can also be found in available genome sequences of B.
pseudomallei and B. thailandensis [34]. Phylogenetic ana-
lysis showed that the sequences from B. pseudomallei are
most closely related to those from B. thailandensis and
other Burkholderia species (Fig. 5c).
PCR for thiaminase I and hydroxyethylthiazole kinase
gene and RT-PCR for mRNA detection in B. pseudomallei
and B. thailandensis
PCR and RT-PCR using specific primers targeting thiami-
nase I gene showed that it is present and expressed in all
the 15 B. pseudomallei and three thailandensis strains.
Therefore, it is unlikely that the increased 4-methyl-5-
thiazoleethanol level in B. pseudomallei is due to thiaminase
I regulation. On the other hand, to test whether the higher
Table 1 Specific metabolites in culture supernatant of B. pseudomallei
m/z Retention
time (min)
Ionization
mode
Ion MS/MS Fragment masses P valuea VIP scoreb Molecular
formula
Putative identity
1 468.3039 4.01 Positive [M + H]+ 86.0983, 98.0997, 125.1071, 143.0960, 198.1260,
266.1878, 281.1615, 366.2501, 392.2288, 425.2962,
451.2754, 468.3016
<0.001 2.15 C19H41N5O8 No match
2 144.048 4.28 Positive [M + H]+ 70.9969, 80.0513, 85.0126, 112.0226, 113.0289,
126.0414
<0.001 1.98 C6H9NOS 4-methyl-5-thiazoleethanol
c
3 433.2228 5.78 Positive [M + H]+ 72.0810, 116.0699, 142.0961, 158.0929, 175.1184,
360.1502, 415.2908
<0.001 1.94 C17H32N6O5S No match
4 512.282 7.16 Positive [M + H]+ 110.0709, 195.0869, 261.0912, 283.0697, 294.1568,
512.2825
<0.001 1.74 C22H37N7O7 Ile His Lys Asp
5 542.2921 7.89 Positive [M + H]+ 70.0654, 86.0963, 90.9760, 183.1480, 274.1853,
283.0696, 421.2550
<0.001 2.12 C21H39N11O6 Pro Arg Arg Asn
6 580.2922 10.1 Positive [M + H]+ 72.081, 112.0866, 175.1187, 305.1612, 433.2229 <0.001 2.05 C21H41N9O8S No match
7d 571.3469/547.3464 21.97 Positive/Negative [M + Na]+/[M-H]− 193.0939, 264.1313, 329.2208, 355.2353, 373.2456,
509.3097, 527.3206,553.3355, 571.3465/ 110.0236,
240.1339, 253.1662, 279.2084, 297.1562, 459.3365,
503.3224, 547.3513
<0.001/<0.001 2.16/ 2.17 C29H48N4O6 No match
8 763.5541 22.28 Positive [M + H]+ 90.9760, 125.1068, 143.0912, 158.9620, 226.9500,
288.9223, 578.4567, 661.4984, 703.5211, 720.5478,
746.5287, 764.5065
<0.001 2.17 C38H70N10O6 No match
ap value from ANOVA analysis
bVIP score based on PLS-DA. VIP score >1 is considered to be statistically significant
cConfirmed by MS/MS fragmentation pattern matching with commercially available authentic chemical standard
dDetected in both positive and negative mode
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Fig. 4 MS/MS mass spectra, box-whisker plots, extracted ion chromatogram and of m/z 144.041 and 4-methyl-5-thiazoleethanol standard. (a) MS/MS
mass spectra, (b) box-whisker plots and (c) extracted ion chromatogram of m/z 144.041 and 4-methyl-5-thiazoleethanol standard. MS/MS fragmentations
were performed at 10, 20 and 40 eV. BC, B. cepacia complex; BPS, B. pseudomallei; BT, B. thailandensis; PA, P. aeruginosa; EC, E. coli
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may be related to reduced downstream degradation, we
attempted to detect the thiM gene, encoding the enzyme,
hydroxyethylthiazole kinase, responsible for downstream
degradation of 4-methyl-5-thiazoleethanol to 4-methyl-5-
(2-phosphonooxyethyl)thiazole. PCR using specific primers
targeting thiM gene showed that thiM gene is present in the
three B. thailandensis strains and 12 of 15 B. pseudomallei
strains, while it is absent in the three B. pseudomallei strains
(B24, B27, VG550A(D10)) showing the highest 4-methyl-5-
thiazoleethanol levels (Fig. 6a). To detect the mRNA expres-
sion of thiM, RT-PCR using specific primers was performed.
The results showed that the thiM gene is expressed in all the
three B. thailandensis strains but not expressed in all 12 B.
pseudomallei strains that possessed the thiM gene (Fig. 6b).
Discussion
Using metabolomics approach, we identified specific me-
tabolites in culture supernatant of B. pseudomallei. Asthese extracellular metabolites are either secreted or re-
leased from cell wall components of B. pseudomallei,
they may be present in the circulating blood or other
body fluids of infected patients, and hence may represent
potential biomarkers for diagnosis. The exclusion of me-
tabolites present in Gram-negative bacteria such as En-
terobacteriaceae and other non-fermenters was important,
since these bacteria are common causes of bacteremia.
Moreover, differentiation of B. pseudomallei from B. thai-
landensis in clinical isolates may be important for accurate
diagnosis of melioidosis, since B. thailandensis is much
less virulent and was only rarely reported to cause invasive
infections in humans [10, 35]. Therefore, the identification
of specific biomarkers for B. pseudomallei may help differ-
entiate melioidosis from other Gram-negative bacterial in-
fections. In this study, both total ion chromatograms and
statistical analyses showed that the metabolomes of the
culture supernatant of B. pseudomallei strains are signifi-
cantly different from those of other tested Gram-negative
Fig. 5 (See legend on next page.)
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Fig. 5 Function and phylogeny of thiaminase I and hydroxyethylthiazole kinase. a Thiaminase I (EC 2.5.1.2) catalyzes the degradation of thiamin
by replacing the thiazole moiety with a variety of nucleophiles. Hydroxyethylthiazole kinase (EC 2.7.1.50) catalyzes the degradation of 4-methyl-5-
thiazoleethanol by transferring the phosphorus-containing groups with an alcohol group as acceptor with ATP. b Phylogenetic tree showing the
relationship of Thiaminase I in B. pseudomallei and B. thailandensis to homologues in other bacteria constructed by maximum-likelihood method.
A total 341 amino acid positions were included in the analysis. Bootstrap values were calculated as percentages from 1000 replicates and only
values ≥70 % were shown. The scale bars indicate the estimated number of substitutions per 5 amino acids. Names and accession numbers are
given as cited in GenBank database. c Phylogenetic tree showing the relationship of hydroxyethylthiazole kinase in B. pseudomallei and B. thailandensis
to homologues in other bacteria constructed by maximum-likelihood method. A total 261 amino acid positions were included in the analysis. Bootstrap
values were calculated as percentages from 1000 replicates and only values ≥70 % were shown. The scale bars indicate the estimated number of
substitutions per 5 amino acids. Names and accession numbers are given as cited in GenBank database
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Using both mutli-and uni-variate analyses, eight metabo-
lites with significantly higher levels in B. pseudomallei
were identified and subject to MS/MS fragmentation for
identification. Most of the metabolites were unidentified
by MS/MS against database matching, suggesting that
these are potential novel compounds. This is not unex-
pected, since metabolomics for the study of microbes is
still an emerging field and the number of known metab-
olites from B. pseudomallei is very limited. Further stud-
ies on the chemical structure and biosynthetic pathway of
these potential novel metabolites would help understand
their biological function in B. pseudomallei. More import-
antly, metabolomics studies on clinical samples from pa-
tients with melioidsosis are warranted to determine if
these B. pseudomallei-specific extracellular metabolites
are present in sufficient quantities in clinical samples of
infected patients to serve as diagnostic biomarkers for
melioidosis.
The presence of high levels of 4-methyl-5-thiazoleethanol
in the culture supernatant of B. pseudomallei strains is
intriguing. Currently, two classes of thiamine degradingFig. 6 PCR for hydroxyethyl thiazole kinase genes and RT-PCR for mRNA d
genomic DNA: thiM is present in the genomes of the three B. thailandensis
in the genomes of three B. pseudomallei strains, B24, B27 and VG550A (D10) w
mRNA of B. thailandensis: thiM is expressed in B. thailandensis strains Bt1, Bt6 a
thiM gene. Housekeeping gene apoB is used for normalizationenzymes, thiaminase I and II, have been identified. Thiaminase
I (EC 2.5.1.2) catalyzes the reaction involving the replace-
ment of organic nucleophiles with the thiazole group in
thiamine. The enzyme can be found in shellfish, fish and
plants, but is only reported in a limited number of bac-
teria such as Bacillus and Clostridium [36]. Thiaminase II
(EC 3.5.99.2), although initially identified with thiamine
degrading activity, is subsequently revealed to be involved
in salvage pathway of thiamine pyrimidine from base-
degraded thiamine [37, 38]. TenA, the gene that encodes
thiaminase II, can be found in bacteria, archaea and eu-
karyotes [38]. In B. pseudomallei, a homologue of the gene
encoding thiaminase I, but not TenA, can be found in the
available complete genome sequences of B. pseudomallei
[39]. Therefore, 4-methyl-5-thiazoleethanol detected in B.
pseudomallei is most likely a product of thiaminase I. The
homologue of thiaminase I in B. pseudomallei is most
closely related to that of B. thailandensis, B. oklahomensis
and B. glumae. Interestingly, such homologue is absent in
other common Gram-negative bacteria such as P. aerugi-
nosa and E. coli, supporting a unique function among
some Burkholderia species. Nevertheless, low levels of 4-etection in B. pseudomallei and B. thailandensis. a PCR of thiM from
strains, Bt1, Bt6 and Bt7, and 12 of 15 B. pseudomallei strains, but absent
ith the highest 4-methyl-5-thiazoleethanol levels. b RT-PCR of thiM from
nd Bt7, but not expressed in the 12 B. pseudomallei strains that possessed
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levels) were also detected in B. cepacia complex, P. aerugi-
nosa and E. coli in this study, which may be due to the
presence of other proteins sharing conserved domains
with thiaminase [40].
Since both B. pseudomallei and B. thailandensis pos-
sessed a thiaminase I homologue with mRNA expression,
we hypothesize that the higher levels of 4-methyl-5-
thiazoleethanol in B. pseudomallei than in B. thailandensis
may be due to accumulation of this compound as a result
of reduced downstream degradation. Hydroxyethylthiazole
kinase (EC 2.7.1.50) is the enzyme responsible for degrad-
ation of 4-methyl-5-thiazoleethanol. It is a phosphotransfer-
ase that catalyzes the transfer of a phosphorus-containing
group of ATP with the alcohol group of 4-methyl-5-
thiazoleethanol as the acceptor, resulting in ADP and 4-
methyl-5-(2-phosphonooxyethyl)thiazole (Fig. 5a). Although
thiM gene that encodes hydroxyethylthiazole kinase can
be found in the available genomes of B. pseudomallei [34],
a previous transcriptome study on B. pseudomallei strain
K94263 showed no detectable expression of thiM when
the bacterium was cultured under 82 different conditions
[41]. In contrast, a transcriptome study on B. thailanden-
sis type strain E264, thiM was found to be expressed [42].
Furthermore, thiM has been classified as one of the non-
core genes in B. pseudomallei and was found to be variably
present among 94 studied strains in an array-based com-
parative genomic hybridization study [41, 43, 44]. Interest-
ingly, in a recent report on whole genome analysis of two
B. pseudomallei strains isolated 139 months apart from the
same patient, thiM was among the 221 genes lost during
reduction evolution [45]. We therefore tested our B. pseu-
domallei and B. thailandensis strains for the presence
of thiM gene and mRNA expression. Our results showed
that thiM gene is either absent or not expressed in all 15
B. pseudomallei strains showing high levels of 4-methyl-
5-thiazoleethanol in culture supernatants. On the con-
trary, thiM gene is present and expressed in the three
B. thailandensis strains showing low levels of 4-methyl-
5-thiazoleethanol. Based on these data, it is likely that the
higher level of 4-methyl-5-thiazoleethanol in B. pseudo-
mallei than in B. thailandensis is the result of lack of thiM
or hydroxyethylthiazole kinase activity.
The present study revealed a unique metabolic path-
way of thiamine degradation in B. pseudomallei resulting
in the accumulation of 4-methyl-5-thiazoleethanol likely
as an end product. Burkholderia species are the only
Gram-negative bacteria that possess thiaminase I gene for
degradation of thiamine to 4-methyl-5-thiazoleethanol. Al-
though thiM can be found in other Gram-negative bac-
teria, they cannot produce 4-methyl-5-thiazoleethanol
from thiamine, which explains the very low levels observed
in E. coli and P. aeruginosa strains. Among the genus
Burkholderia, both thiaminase I and thiM genes canbe found in available genome sequences of B. pseudomal-
lei, B. thailandensis, B. oklahomensis and B. glumae in
GenBank (Fig. 5b and c). The presence of thiM gene with
mRNA expression in the three B. thailandensis strains, in
line with the previous transcriptome study [42], supports
hydroxyethylthiazole kinase activity and explains the low
4-methyl-5-thiazoleethanol level as a result of degradation
to 4-methyl-5-(2-phosphonooxyethyl)thiazole. In con-
trast, although thiM gene can be found in some reported
B. pseudomallei strains, previous studies showed that the
gene may be absent, not expressed or lost during evolution
[41, 43–45]. As supported by the present study, B. pseudo-
mallei likely lacks hydroxyethylthiazole kinase activity and
hence is unable to degrade 4-methyl-5-thiazoleethanol. Al-
though B. oklahomensis and B. glumae also possess both
thiaminase I and thiM genes, they are not pathogenic to
humans. Therefore, 4-methyl-5-thiazoleethanol may rep-
resent a specific biomarker for clinical isolates suspicious
of B. pseudomallei. Further studies may be performed to
elucidate potential biological and pathogenic role of this
unique metabolic pathway and high levels of 4-methyl-5-
thiazoleethanol in B. pseudomallei.
Metabolomics is an emerging tool in studying microbes
and infectious diseases. The technique offers a revolu-
tionary approach to study both the pathogen itself as well
as the host response to infections, providing insights on
diagnosis, pathogenesis, host-pathogen interactions and
metabolic pathways. Metabolomic data obtained from
urine samples have been used to distinguish healthy sub-
jects from patients with pneumococcal disease and urinary
tract infections [46–48]. A study using nuclear magnetic
resonance spectroscopy-based metabolomics also showed
that the metabolic profile of sera from tuberculosis pa-
tients can be distinguished from those from healthy con-
trols [49]. In another study using serum metabolomics
approach on leprosy patients, higher levels of polyunsatur-
ated fatty acids were found among patients having higher
bacterial indices, which may provide clues on biological
pathways involved in the immunomodulation of leprosy
[50]. With the increasing applications of metabolomics
technology on both microbial and clinical samples from
patients with appropriate controls, we expect to witness
an exponential expansion of our knowledge on microbial
metabolites, including the discovery of novel metabolites
and potential biomarkers for diagnosis of infections such
as melioidosis. In particular, application of metabolomics
for diagnosis of culture-negative melioidosis is potentially
advantageous over other diagnostic methods such as sero-
logical and PCR assays. First, the detection of metabolites
by mass spectrometry offers high specificity, devoid of the
problem of cross-reacting antibodies as in serological as-
says and false-positive PCR reactions as a result of DNA
from host or other bacteria. Second, the same metabolo-
mics platform can be extended for detection of different
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eases. Although the equipment and expertise for metabolo-
mics technology is currently not available in most clinical
microbiology laboratories, the success of matrix-assisted
laser-desorption ionization time-of-flight mass spectrom-
etry as a revolutionary method for pathogen identification
suggests that mass spectrometry may emerge as a new tool
for diagnostic microbiology. New diagnostic tests for poten-
tial biomarkers may also be developed in other platforms
that are easy to use in clinical laboratories.Conclusion
The present study illustrates the power of the state-of-
the-art metabolomics technology in exploring potential
biomarkers in B. pseudomallei. Eight metabolites with sig-
nificant higher levels were identified in culture superna-
tants of B. pseudomallei compared to other tested bacterial
species, including 4-methyl-5-thiazoleethanol and two tet-
rapeptides, Ile-His-Lys-Asp and Pro-Arg-Arg-Asn. The
high level of 4-methyl-5-thiazoleethanol in B. pseudomallei
is likely due to the absence of hydroxyethylthiazole kinase
and hence reduced downstream degradation. Further stud-
ies of the B. pseudomallei-specific metabolites would help
understand their biological significance and potential role
as diagnostic biomarkers.Materials and methods
Bacterial strains and culture
Fifteen B. pseudomallei (seven clinical and eight environ-
mental isolates), three B. thailandensis, 14 B. cepacia com-
plex, four Pseudomonas aeruginosa and three Escherichia
coli isolates were included in this study (Additional file 1:
Table S1). All isolates were phenotypically identified by the
API 20NE system (bioMérieux Vitek, Hazelwood, MO),
supplemented by conventional biochemical methods [51].
All B. pseudomallei, B. thailandensis and B. cepacia com-
plex strains were isolated and characterized in previous
studies [23, 52]. Each bacterial strain was grown on sheep
blood agar at 37 °C overnight. Single colony was inoculated
from blood agar to 5 ml RPMI 1640 medium (Gibco,
Carlsbad, CA, USA) for incubation at 37 °C with shaking
at 200 rpm for 24 h. The primary sub-cultures were ad-
justed to OD600 0.2 and 1 mL of the diluted culture was
further sub-cultured in 30 ml of fresh RPMI medium
at 37 °C with shaking at 200 rpm for 24 h. The sec-
ondary sub-cultures were centrifuged at 3,000 rpm for
30 min to obtain the supernatant which was filtered twice
using 0.22 μm filters. Metabolic activities in the filtrates
were quenched immediately by incubating the filtrates
in liquid nitrogen for 10 min. The filtrates were ly-
ophilized and stored at–80 °C until sample extraction
and analysis. Uninoculated culture medium was used as
negative control.Chemicals and reagents
LC-MS grade water, methanol and acetonitrile was pur-
chased from J.T. Baker (Center Valley, PA, USA). Analytical
grade acetic acid, 5 M ammonium acetate and standard
chemical 4-methyl-5-thiazoleethanol were purchased from
Sigma-Aldrich, Inc (Saint Louis, MO, USA).
Sample preparation
Lyophilized samples were reconstituted by dissolving in
1 mL solvent mixture containing water/methanol/acetonitrile
(1:2:2). The samples were vortexed for 1 min and subse-
quently sonicated for 10 min at room temperature. After
centrifugation at 15,000 × g for 15 min at 4 °C, superna-
tants were transferred to LC vial for LC-MS analysis.
LC-MS system
For liquid chromatography, the separation was performed
by Agilent 1290 UHPLC (Agilent Technologies, USA) and
Agilent Eclipse Plus RRHD C18 (2.1 × 100 mm, 1.8 μm)
column with Agilent Eclipse Plus RRHT C18 (2.1 × 30 mm,
1.8 μm) guard column. The injection volume was 3 μl.
The column and autosampler temperature were main-
tained at 45 °C and 10 °C, respectively. The separation was
performed at a flow rate of 0.4 mL/min under a gradient
program in which mobile phase A was composed of
5 mM ammonium acetate in water containing 0.1 % acetic
acid (v/v) and mobile phase B was composed of 0.05 %
acetic acid (v/v) in acetonitrile. The gradient program was
applied as follows: t = 0 min, 5 % B; t = 0.25 min, 5 % B;
t = 20 min, 80 % B; t = 23 min, 99 % B; t = 33 min, 99.5 %
B; t = 33.1 min, 99.5 % B. The stop time was 40 min. For
MS, data was acquired by Agilent 6540 Q-TOF mass spec-
trometer (Agilent Technologies, USA) operating in the
positive and negative ion mode using Agilent Jet Stream
Electrospray ionization (ESI) source. The capillary voltage
was set at +3800 V (positive mode) and-3800 V (negative
mode) with nozzle voltages of +0 V and-0 V, respectively.
Other source conditions were kept constant in all the
experiments as follow: gas temperature was kept con-
stant at 300 °C, drying gas (nitrogen) was set at the rate
of 7 L/min, and the pressure of nebulizer gas (nitrogen)
was 40 psi. The sheath gas was kept at a flow rate of
10 L/min and was maintained at a temperature of
330 °C. The voltages of the Fragmentor, Skimmer 1, and
OctopoleRFPeak were 135 V, 65 V and 750 V respectively.
The scan range was adjusted to 80–1700 m/z at the acqui-
sition rate of 2 spectra/s. MS/MS acquisition was operated
in the same parameter as in MS acquisition. Collision
Energy (CE) was used at 20 or 40 eV for fragmentation of
the targeted compounds.
Data processing and statistical data analysis
All mass spectral data was acquired using Agilent MassHunter
Qualitative Analysis software (version B.05.00, Agilent
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discovery, two software packages: Mass Hunter Qualita-
tive Analysis and open-source software XCMS (version
1.38.0) operating in R, which adopted different peak detec-
tion and alignment algorithms, were used [53]. For Mass
Hunter Qualitative Analysis software, data preprocessing
including baseline correction, noise calculations and mo-
lecular features extraction were performed with built-in
small molecule extraction algorithm. Data was subse-
quently processed using Mass Profiler Professional (MPP)
(Agilent Technologies) for peak alignment, data filter-
ing and statistical analysis. For XCMS, raw data files
were first converted to mzDATA format and peak de-
tection were performed with centWave alogrithm in
XCMS [54]. Data was subsequently processed using XCMS
for peak alignment and data filtering. MetaboAnalyst 2.0
(www.metaboanalyst.ca) [55] was used for statistical ana-
lysis [55]. Further data processing including normalization,
scaling and filtering were performed prior to statistical
analysis in both software. Only variables that are present in
at least 60 % of any group and with intensity of at least
4.0E + 03 were included for analysis in order to reduce
noise and low abundance metabolites. The MS data were
log2-transformed and mean-centered with unit variance
scaling for statistical analysis. PCA and hierarchical cluster-
ing were performed for unsupervised multivariate statis-
tical analysis. PLS-DA were performed as supervised
method to identify important variables with discriminative
power. PLS-DA models were validated based on multiple
correlation coefficient (R2) and cross-validated R2 (Q2) in
cross-validation and permutation test by applying 2000 it-
erations (p > 0.001). The significance of the biomarkers
was ranked using the variable importance in projection
(VIP) score (>1) from the PLS-DA model. For univariate
analysis of candidate specific biomarkers in culture super-
natant, statistical significance was determined using one-
way ANOVA with Tukey’s post-hoc test between different
bacterial species (B. pseudomallei, B. thailandensis, B.
cepacia complex, P. aeruginosa and E. coli) and Student’s
t-test for comparison between B. pseudomallei and other
bacterial species. P < 0.05 was considered to be statistically
significant. Volcano plot with fold change >5 and P < 0.05
was performed where appropriate. Box-whisker plots
were produced using GraphPad Prism software (GraphPad
Software Inc., California, USA). Extracted ion chro-
matograms of potential specific metabolites identified by
statistical analysis were manually viewed to confirm the
differences in peak areas between MTB and NTB samples.
Metabolites were further filtered using CAMERA package
in R, Mass Hunter and manual inspection to exclude pos-
sible fragments, dimers, adducts and isotopes [56]. Spe-
cific metabolites that were detected by both MPP and
MetaboAnalyst to be statistically significant were consid-
ered to be potential biomarkers.Metabolite identification
MS/MS fragmentation was performed on the identified
potential specific biomarkers. Identification of potential
biomarkers was carried out by METLIN database (http://
metlin.scripps.edu/) [57], Human Metabolome Database
(HMDB) (http://www.hmdb.ca/) [58], E. coli Metabolome
Database (ECMDB) (http://www.ecmdb.ca/) [59], MassBank
(http://www.massbank.jp/) [60], LipidMaps (http://www.
lipidmaps.org/) [61] and/or KEGG database (http://
www.genome.jp/kegg) [62] search using exact molecular
weights or MS/MS fragmentation pattern data and litera-
ture search. For confirmation of metabolite identity using
authentic chemical standard, MS/MS fragmentation pat-
tern of chemical standard was compared with that of can-
didate metabolite under same LC-MS condition to reveal
any matching. In case of unknown metabolites, molecular
formulae were generated using Mass Profiler Professional.
Phylogenetic analysis of thiaminase I and hydroxyethyl
thiazole kinase genes in B. pseudomallei and
B. thailandensis
The protein sequences of bacterial thiaminase I and hydro-
xyethyl thiazole kinase were retrieved from Genbank.
Phylogenetic trees were constructed using the maximum-
likelihood method with 1000 bootstrap replicates with
Mega 5.1 [63]. WAG+G amino acid substitution model
with 5 gamma categories was used.
PCR for thiaminase I and hydroxyethyl thiazole kinase
genes and RT-PCR for mRNA detection in B. pseudomallei
and B. thailandensis
Genomic DNA was extracted from 15 B. pseudomallei
and three B. thailandensis strains using DNeasy mini Kit
(Qiagen, Hilden, Germany). Total RNA was extracted
using RNeasy mini Kit (Qiagen, Hilden, Germany) accord-
ing to manufacturer’s instructions. The purified RNA was
subjected to DNase I treatment using TURBO DNA-free
kit (Ambion, USA). Reverse transcription was performed
using the Superscript III kit (Invitrogen, Carlsbad, CA)
according to manufacturer’s instructions. The resultant
genomic DNA or cDNA s were then used for PCR amplifi-
cation. The PCR mixture (25 μL) contained genomic DNA
or cDNA (1.0 μL) as template, 0.5 μM primers, 2.5 μL 10×
PCR buffer II, 2.5 mM MgCl2, 200 μM of each dNTPs
(GeneAmp, Applied Biosystems, Waltham, Massachusetts,
USA) and 1.0U Taq polymerase (AmpliTaq Gold; Applied
Biosystems, Waltham, Massachusetts, USA). Thermal cyc-
ling was performed in an automated thermocycler (Veriti
96-well fast thermal cycler; Applied Biosystems, Waltham,
Massachusetts, USA) with a hot-start at 95 °C for 10 min;
35 cycles of 95 °C for 30 s, annealing for 30 s at tempera-
tures of 53 °C and 72 °C for 30 s and a final extension at
72 °C for 10 min. Five microliters of each amplified prod-
uct was electrophoresed in 2.5 % (w/v) agarose gel with a
Lau et al. Cell & Bioscience  (2015) 5:26 Page 13 of 14molecular size marker (GeneRuler 50 bp DNA Ladder;
Fermentas, Pittsburgh, PA, USA) in parallel. Electrophor-
esis in Tris-borate-EDTA buffer was performed at 120 V
for 35 min. The gel was stained with ethidium bromide
(0.5 μg/mL) for 25 min, rinsed and photographed under
ultraviolet light illumination. Standard precautions were
taken to avoid PCR contamination, and no false-positive
was observed in negative controls. The primers used are as
shown in Additional file 2: Table S2. Housekeeping gene
apoB was used for normalization.
Additional files
Additional file 1: Table S1. Bacterial strains used in this study.
Additional file 2: Table S2. Primers used in this study.
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